• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往感染者接种一剂 COVID-19 疫苗后的免疫记忆和中和活性。

Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals.

机构信息

Institute of Translational Research, Department of Molecular Biology, Asian Healthcare Foundation, AIG Hospitals Complex, Mindspace Road, Gachibowli, Hyderabad, 500032, Telangana, India.

Institute of Translational Research, Department of Molecular Biology, Asian Healthcare Foundation, AIG Hospitals Complex, Mindspace Road, Gachibowli, Hyderabad, 500032, Telangana, India.

出版信息

Int J Infect Dis. 2021 Jul;108:183-186. doi: 10.1016/j.ijid.2021.05.034. Epub 2021 May 19.

DOI:10.1016/j.ijid.2021.05.034
PMID:34022331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8132551/
Abstract

BACKGROUND

The efficacy of COVID-19 vaccines to generate immunological memory post-vaccination has not previously been studied.

OBJECTIVE

To assess immunological memory in previously SARS-CoV-2 infected individuals after a single dose of mRNA vaccine.

PATIENTS AND METHODS

Healthcare workers (n = 280) were enrolled after obtaining written informed consent and grouped under previously infected and no prior exposure (reverse transcription-polymerase chain reaction positive and negative, respectively). Blood was drawn at baseline and post-vaccination (single dose of COVISHIELD) for enumerating neutralizing antibodies by chemiluminescence and memory T- and B-cells by flow cytometry.

RESULTS

Post vaccination, compared with the no prior exposure group, the previously infected group had higher levels of: antibody response (1124.73 ± 869.13 vs 94.23 ± 140.06 AU/ml, p = 0.0001); CD4 memory T-cells: central memory CCR7+CD45RA- (p = 0.0001), effector memory CCR7-/CD45RA- (p = 0.01); total CD8+ T-cells (p = 0.004); CD8+ naïve T-cells CCR7+CD45RA+ (p = 0.01); and memory B-cells CD20+CD27+ (p = 0.0001).

DISCUSSION

Single-dose vaccination elicited higher neutralizing antibody response and protective immunity in individuals who had recovered from SARS-CoV-2 infection compared with those with no prior exposure.

摘要

背景

COVID-19 疫苗接种后产生免疫记忆的效果此前尚未研究过。

目的

评估单剂 mRNA 疫苗接种后既往 SARS-CoV-2 感染者的免疫记忆。

患者和方法

在获得书面知情同意后,招募了 280 名医护人员,并根据既往感染和无既往暴露(分别为逆转录-聚合酶链反应阳性和阴性)将其分为两组。在基线和接种疫苗后(单次接种 COVISHIELD)抽取血液,通过化学发光法检测中和抗体,通过流式细胞术检测记忆 T 细胞和 B 细胞。

结果

与无既往暴露组相比,既往感染组在接种疫苗后具有更高水平的:抗体反应(1124.73±869.13 与 94.23±140.06 AU/ml,p=0.0001);CD4 记忆 T 细胞:中央记忆 CCR7+CD45RA-(p=0.0001),效应记忆 CCR7-/CD45RA-(p=0.01);总 CD8+T 细胞(p=0.004);CD8+幼稚 T 细胞 CCR7+CD45RA+(p=0.01);以及记忆 B 细胞 CD20+CD27+(p=0.0001)。

讨论

与无既往暴露者相比,既往 SARS-CoV-2 感染者单剂疫苗接种可引起更高的中和抗体反应和保护性免疫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/548a/8132551/da8cc8c10c56/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/548a/8132551/da8cc8c10c56/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/548a/8132551/da8cc8c10c56/gr1_lrg.jpg

相似文献

1
Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals.既往感染者接种一剂 COVID-19 疫苗后的免疫记忆和中和活性。
Int J Infect Dis. 2021 Jul;108:183-186. doi: 10.1016/j.ijid.2021.05.034. Epub 2021 May 19.
2
SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.SARS-CoV-2 特异性 T 细胞记忆在 COVID-19 恢复期患者中持续存在 10 个月,成功发育出干细胞样记忆 T 细胞。
Nat Commun. 2021 Jun 30;12(1):4043. doi: 10.1038/s41467-021-24377-1.
3
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.一剂自我转录和复制的基于 RNA 的 SARS-CoV-2 疫苗可在小鼠中产生保护性适应性免疫。
Mol Ther. 2021 Jun 2;29(6):1970-1983. doi: 10.1016/j.ymthe.2021.04.001. Epub 2021 Apr 5.
4
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.立陶宛血液系统恶性肿瘤患者的 BNT162b2 COVID-19 mRNA 疫苗免疫原性和早期临床结局:一项全国前瞻性队列研究。
Lancet Haematol. 2021 Aug;8(8):e583-e592. doi: 10.1016/S2352-3026(21)00169-1. Epub 2021 Jul 2.
5
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2.先前感染过 SARS-CoV-2 的个体对 BNT162b2 mRNA 疫苗的抗体反应。
Nat Med. 2021 Jun;27(6):981-984. doi: 10.1038/s41591-021-01325-6. Epub 2021 Apr 1.
6
The clinical and immunological characteristics of COVID-19 patients with delayed SARS-CoV-2 virus clearance.新冠病毒清除延迟患者的临床和免疫学特征。
Immun Inflamm Dis. 2023 Sep;11(9):e999. doi: 10.1002/iid3.999.
7
Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines.对 SARS-CoV-2 感染和 COVID-19 疫苗的免疫记忆。
Immunol Rev. 2022 Sep;310(1):27-46. doi: 10.1111/imr.13089. Epub 2022 Jun 22.
8
Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.COVID-19 对人外周血白细胞群体的免疫印迹。
Allergy. 2021 Mar;76(3):751-765. doi: 10.1111/all.14647. Epub 2020 Nov 22.
9
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection.一剂 BNT162b2 mRNA COVID-19 疫苗可显著增强无症状或轻症自然 SARS-CoV-2 感染后康复的医护人员的中和抗体反应。
Int J Infect Dis. 2021 Jul;108:176-178. doi: 10.1016/j.ijid.2021.05.033. Epub 2021 May 19.
10
Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine.强化的抗体反应表明,在接种两剂 SARS-CoV-2 灭活疫苗的个体中存在免疫记忆。
Emerg Microbes Infect. 2021 Dec;10(1):1112-1115. doi: 10.1080/22221751.2021.1937328.

引用本文的文献

1
Longitudinal Immunoprofiling of the CD8 T-Cell Response in SARS-CoV-2 mRNA Vaccinees and COVID-19 Patients.新冠病毒mRNA疫苗接种者和新冠肺炎患者中CD8 T细胞反应的纵向免疫分析
Vaccines (Basel). 2025 May 22;13(6):551. doi: 10.3390/vaccines13060551.
2
Receptor Binding Domain-Specific B Cell Memory Responses Among Individuals Vaccinated Against SARS-CoV-2.接种 SARS-CoV-2 疫苗个体中的受体结合域特异性 B 细胞记忆反应。
Vaccines (Basel). 2024 Dec 12;12(12):1396. doi: 10.3390/vaccines12121396.
3
Antibody Response to SARS-CoV-2 Vaccines in Transplant Recipients and Hemodialysis Patients: Data from the Dominican Republic.
移植受者和血液透析患者对SARS-CoV-2疫苗的抗体反应:来自多米尼加共和国的数据。
Vaccines (Basel). 2024 Nov 23;12(12):1312. doi: 10.3390/vaccines12121312.
4
Detection and comparison of SARS-CoV-2 antibody produced in naturally infected patients and vaccinated individuals in Addis Ababa, Ethiopia: multicenter cross-sectional study.在埃塞俄比亚亚的斯亚贝巴,对自然感染患者和接种个体产生的 SARS-CoV-2 抗体进行检测和比较:多中心横断面研究。
Virol J. 2024 Aug 19;21(1):192. doi: 10.1186/s12985-024-02443-6.
5
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial.RAZI 重组刺突蛋白疫苗(RCP)作为 BBIBP-CorV 初免后的加强针的免疫原性和安全性:一项平行、两组、随机、双盲试验。
BMC Med. 2024 Feb 20;22(1):78. doi: 10.1186/s12916-024-03295-1.
6
How immune breakthroughs could slow disease progression and improve prognosis in COVID-19 patients: a retrospective study.免疫突破如何减缓 COVID-19 患者的疾病进展并改善预后:一项回顾性研究。
Front Immunol. 2023 Oct 23;14:1246751. doi: 10.3389/fimmu.2023.1246751. eCollection 2023.
7
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELD and COVAXIN induced immunity in COVID-19 exposed Indians.与中和抗体相关的多功能CD4 T细胞是COVISHIELD和COVAXIN在接触过新冠病毒的印度人身上诱导免疫的一个标志。
NPJ Vaccines. 2023 Sep 14;8(1):134. doi: 10.1038/s41541-023-00731-w.
8
Effect of COVID-19 Vaccination on the Levels of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Naive, Hybrid, and Breakthrough SARS-CoV-2 Recovered Indian Individuals.新冠疫苗接种对从未感染过新冠病毒、混合免疫及突破感染后康复的印度个体中新冠病毒中和抗体水平的影响
J Lab Physicians. 2023 Feb 6;15(3):377-382. doi: 10.1055/s-0043-1761454. eCollection 2023 Sep.
9
Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines.混合免疫扩大了 mRNA 和基于载体的 SARS-CoV-2 疫苗的功能性体液免疫记忆。
Cell Rep Med. 2023 May 16;4(5):101048. doi: 10.1016/j.xcrm.2023.101048. Epub 2023 Apr 25.
10
Likelihood of COVID-19 reinfection in an urban community cohort in Massachusetts.马萨诸塞州一个城市社区队列中新冠病毒再次感染的可能性。
Dialogues Health. 2022 Dec;1:100057. doi: 10.1016/j.dialog.2022.100057. Epub 2022 Oct 8.